Medigus Ltd. - Warrants - Series C (23/07/2023)
MDGSW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.34K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $16,337.00 |
|---|---|
| Enterprise Value | $4.34 Million |
| Earnings per Share | $-8.36 |
| Beta | 0 |
| Outstanding Shares | 766,975 |
Return
| Return on Equity | -92.44% |
|---|---|
| Return on Assets | -34.11% |
| Return on Invested Capital | -41.73% |
Valuation & Multiples
| P/E Ratio | -0.61 |
|---|---|
| PEG | -0.47 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.03 |
| Enterprise Value to EBIT | -0.3 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 3.15 |
| Debt to Equity | 0.58 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Medigus Ltd.
2,020 employees
Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions across medical and industrial applications.